Literature DB >> 11981218

Adrenalectomy for familial pheochromocytoma in the laparoscopic era.

L Michael Brunt1, Terry C Lairmore, Gerard M Doherty, Mary A Quasebarth, Mary DeBenedetti, Jeffrey F Moley.   

Abstract

OBJECTIVE: To report the results of treatment of patients with familial pheochromocytomas in the laparoscopic era. SUMMARY BACKGROUND DATA: The optimal surgical management of pheochromocytomas that arise in familial neoplasia syndromes may be complicated by bilateral involvement and associated endocrinopathies.
METHODS: Twenty-one patients with familial pheochromocytomas (15 with multiple endocrine neoplasia [MEN] 2A, 4 with MEN 2B, 1 each with von Hippel-Lindau and neurofibromatosis type 1) underwent adrenalectomy between December 1993 and July 2001. Clinical, biochemical, and pathologic data were obtained by retrospective review of perioperative medical records, postoperative biochemical testing, and patient questionnaire.
RESULTS: Mean age at diagnosis was 37 +/- 11 years. Twenty of the 21 patients had elevated urine catecholamines, and all had radiographic evidence of an adrenal tumor or tumors. Pheochromocytoma-related symptoms were present in 11 patients (52%). One patient with MEN 2B underwent open adrenalectomy due to previous adrenal surgery and megacolon. Laparoscopic adrenalectomy was attempted in the remaining 20 patients (9 right, 11 left, 2 bilateral). Two patients (9.1%) were converted to open adrenalectomy. Intraoperative hypertensive episodes occurred in 15 patients (71%) and were easily controlled medically. Mean operative time was 216 +/- 57 minutes, mean postoperative length of stay was 3.1 +/- 1.3 days, and mean tumor size was 3.1 +/- 1.0 cm. Minor complications occurred in three patients (14.3%) and major complications in two patients (9.5%). During a mean follow-up of 57 months, a contralateral pheochromocytoma developed in four patients with MEN 2 (33%); three of them underwent adrenalectomy. There have been no long-term complications related to hypertension or adrenalectomy.
CONCLUSIONS: This study is the largest series of patients with familial pheochromocytoma undergoing adrenalectomy during the laparoscopic era. The results suggest that the laparoscopic approach is safe and effective for managing unilateral or bilateral adrenal medullary disease in this population.

Entities:  

Mesh:

Year:  2002        PMID: 11981218      PMCID: PMC1422498          DOI: 10.1097/00000658-200205000-00014

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  56 in total

1.  Clinical experience over 48 years with pheochromocytoma.

Authors:  R E Goldstein; J A O'Neill; G W Holcomb; W M Morgan; W W Neblett; J A Oates; N Brown; J Nadeau; B Smith; D L Page; N N Abumrad; H W Scott
Journal:  Ann Surg       Date:  1999-06       Impact factor: 12.969

2.  Proposed classification of complications of surgery with examples of utility in cholecystectomy.

Authors:  P A Clavien; J R Sanabria; S M Strasberg
Journal:  Surgery       Date:  1992-05       Impact factor: 3.982

3.  Clinical and genetic characterization of pheochromocytoma in von Hippel-Lindau families: comparison with sporadic pheochromocytoma gives insight into natural history of pheochromocytoma.

Authors:  M M Walther; R Reiter; H R Keiser; P L Choyke; D Venzon; K Hurley; J R Gnarra; J C Reynolds; G M Glenn; B Zbar; W M Linehan
Journal:  J Urol       Date:  1999-09       Impact factor: 7.450

4.  A case-controlled study of laparoscopic compared with open lateral adrenalectomy.

Authors:  T Imai; T Kikumori; M Ohiwa; T Mase; H Funahashi
Journal:  Am J Surg       Date:  1999-07       Impact factor: 2.565

5.  Plasma normetanephrine and metanephrine for detecting pheochromocytoma in von Hippel-Lindau disease and multiple endocrine neoplasia type 2.

Authors:  G Eisenhofer; J W Lenders; W M Linehan; M M Walther; D S Goldstein; H R Keiser
Journal:  N Engl J Med       Date:  1999-06-17       Impact factor: 91.245

Review 6.  von Recklinghausen's disease and pheochromocytomas.

Authors:  M M Walther; J Herring; E Enquist; H R Keiser; W M Linehan
Journal:  J Urol       Date:  1999-11       Impact factor: 7.450

7.  Mutations in the RET proto-oncogene are associated with MEN 2A and FMTC.

Authors:  H Donis-Keller; S Dou; D Chi; K M Carlson; K Toshima; T C Lairmore; J R Howe; J F Moley; P Goodfellow; S A Wells
Journal:  Hum Mol Genet       Date:  1993-07       Impact factor: 6.150

8.  Management of pheochromocytomas in patients with multiple endocrine neoplasia type 2 syndromes.

Authors:  T C Lairmore; D W Ball; S B Baylin; S A Wells
Journal:  Ann Surg       Date:  1993-06       Impact factor: 12.969

9.  Germ-line mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2A.

Authors:  L M Mulligan; J B Kwok; C S Healey; M J Elsdon; C Eng; E Gardner; D R Love; S E Mole; J K Moore; L Papi
Journal:  Nature       Date:  1993-06-03       Impact factor: 49.962

10.  von Hippel-Lindau syndrome: cloning and identification of the plasma membrane Ca(++)-transporting ATPase isoform 2 gene that resides in the von Hippel-Lindau gene region.

Authors:  F Latif; F M Duh; J Gnarra; K Tory; I Kuzmin; M Yao; T Stackhouse; W Modi; L Geil; L Schmidt
Journal:  Cancer Res       Date:  1993-02-15       Impact factor: 12.701

View more
  19 in total

1.  Pure Laparoscopic Versus Open Left Lateral Sectionectomy for Hepatocellular Carcinoma: A Single-Center Experience.

Authors:  Tan To Cheung; Ronnie T P Poon; Wing Chiu Dai; Kenneth S H Chok; See Ching Chan; Chung Mau Lo
Journal:  World J Surg       Date:  2016-01       Impact factor: 3.352

2.  Minimally invasive resection of adrenal masses in infants and children: results of a European multi-center survey.

Authors:  Francesco Fascetti-Leon; Giovanni Scotton; Luca Pio; Raimundo Beltrà; Paolo Caione; Ciro Esposito; Girolamo Mattioli; Amulya K Saxena; Sabine Sarnacki; Piergiorgio Gamba
Journal:  Surg Endosc       Date:  2017-05-26       Impact factor: 4.584

Review 3.  Update on pediatric pheochromocytoma.

Authors:  Bas Havekes; Johannes A Romijn; Graeme Eisenhofer; Karen Adams; Karel Pacak
Journal:  Pediatr Nephrol       Date:  2008-06-20       Impact factor: 3.714

4.  Clinical presentation of Von Hippel Lindau syndrome type 2B associated with VHL p.A149S mutation in a large Turkish family.

Authors:  T Mete; D Berker; E Yilmaz; G Ozgen; Y Yalcin; M Tuna; D Ciliz; M Onen; Y Aydin; S Guler
Journal:  Endocrine       Date:  2013-05-15       Impact factor: 3.633

Review 5.  Molecular genetic alterations in adrenal and extra-adrenal pheochromocytomas and paragangliomas.

Authors:  Hilde Dannenberg; Paul Komminoth; Winand N M Dinjens; Ernst Jan M Speel; Ronald R de Krijger
Journal:  Endocr Pathol       Date:  2003       Impact factor: 3.943

6.  Pheochromocytoma in an 8-year-old patient with multiple endocrine neoplasia type 2A: implications for screening.

Authors:  Kathryn J Rowland; Rebecca D Chernock; Jeffrey F Moley
Journal:  J Surg Oncol       Date:  2013-07-19       Impact factor: 3.454

7.  Mutations and polymorphisms in the SDHB, SDHD, VHL, and RET genes in sporadic and familial pheochromocytomas.

Authors:  Jens Waldmann; Peter Langer; Nils Habbe; Volker Fendrich; Anette Ramaswamy; Matthias Rothmund; Detlef K Bartsch; Emily P Slater
Journal:  Endocrine       Date:  2009-04-28       Impact factor: 3.633

8.  Pheochromocytoma in MEN 2A syndrome. Study of 54 patients.

Authors:  Jose M Rodriguez; Maria Balsalobre; Jose L Ponce; Antonio Ríos; Nuria M Torregrosa; Javier Tebar; Pascual Parrilla
Journal:  World J Surg       Date:  2008-11       Impact factor: 3.352

9.  Risk factors affecting operative approach, conversion, and morbidity for adrenalectomy: a single-institution series of 402 patients.

Authors:  James G Bittner; Victoria M Gershuni; Brent D Matthews; Jeffrey F Moley; L Michael Brunt
Journal:  Surg Endosc       Date:  2013-02-13       Impact factor: 4.584

10.  The characterization of pheochromocytoma and its impact on overall survival in multiple endocrine neoplasia type 2.

Authors:  Sonali Thosani; Montserrat Ayala-Ramirez; Lynn Palmer; Mimi I Hu; Thereasa Rich; Robert F Gagel; Gilbert Cote; Steven G Waguespack; Mouhammed Amir Habra; Camilo Jimenez
Journal:  J Clin Endocrinol Metab       Date:  2013-09-12       Impact factor: 5.958

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.